{"transactions":[{"id":873558,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"officer":true,"officer_title":"Chief Business & Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-02T17:09:21.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable as follows: 25% of the shares on the one-year anniversary of the Grant Date, with the remaining 75% vesting and becoming exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":120000,"derivative":{"exercise_price":6.22,"expiration_date":"2036-02-29","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001835597-26-000010","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551776/000183559726000010/form4.xml","form_type":"4"}},{"id":873557,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"officer":true,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-02T17:09:21.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":30717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 30,717 restricted stock units (\"RSUs\"), each representing the contingent right to receive one share of Common Stock upon vesting. The RSUs vest in equal annual installments over four years, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":65717,"source":{"system":"sec-edgar","filing":"0001835597-26-000010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551776/000183559726000010/form4.xml","form_type":"4"}},{"id":974083,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"officer":true,"officer_title":"Chief Business & Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-10T17:08:57.000Z","date":"2025-12-08","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the Reporting Person's continued service or employment with the Company on each applicable vesting date."}],"balance_after":160000,"derivative":{"exercise_price":5.59,"expiration_date":"2035-12-07","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001835597-25-000009","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551776/000183559725000009/form4.xml","form_type":"4"}},{"id":974082,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"officer":true,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-10T17:08:57.000Z","date":"2025-12-08","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Consists of shares of Common Stock issuable under 35,000 restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on December 8, 2026, subject to the Reporting Person's continued service or employment with the Company on each applicable vesting date."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001835597-25-000009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551776/000183559725000009/form4.xml","form_type":"4"}},{"id":1124585,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2025-06-03T18:02:16.000Z","date":"2025-06-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each performance-based restricted stock unit award with respect to shares that is, at the time of determination, subject to performance-based vesting or forfeiture conditions (\"PSU Award\") that is outstanding and vested as of immediately prior thereto, or which shall become vested as required under the terms governing the PSU Award, shall by virtue of the Merger automatically and (except as otherwise provided in the Merger Agreement) without any action on the part of the Issuer, Parent or the holder thereof, be canceled and terminated and converted into the right to receive"},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"(Continued from footnote 5) (i) an amount in cash equal to the product of the number of shares underlying such PSU Award immediately prior to the Effective Time (assuming that the applicable performance goals have been deemed to be achieved at the greater of target and actual level of performance as determined by the Compensation Committee of the Issuer's board of directors in its discretion) and $3.00 in cash, subject to any applicable withholding taxes and without interest thereon plus (ii) one CVR with respect to each such share subject to such PSU Award immediately prior to the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-081175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000095017025081175/ownership.xml","form_type":"4"}},{"id":1124584,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2025-06-03T18:02:16.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each performance-based restricted stock unit award with respect to shares that is, at the time of determination, subject to performance-based vesting or forfeiture conditions (\"PSU Award\") that is outstanding and vested as of immediately prior thereto, or which shall become vested as required under the terms governing the PSU Award, shall by virtue of the Merger automatically and (except as otherwise provided in the Merger Agreement) without any action on the part of the Issuer, Parent or the holder thereof, be canceled and terminated and converted into the right to receive"},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"(Continued from footnote 5) (i) an amount in cash equal to the product of the number of shares underlying such PSU Award immediately prior to the Effective Time (assuming that the applicable performance goals have been deemed to be achieved at the greater of target and actual level of performance as determined by the Compensation Committee of the Issuer's board of directors in its discretion) and $3.00 in cash, subject to any applicable withholding taxes and without interest thereon plus (ii) one CVR with respect to each such share subject to such PSU Award immediately prior to the Effective Time."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0000950170-25-081175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000095017025081175/ownership.xml","form_type":"4"}},{"id":1124583,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2025-06-03T18:02:16.000Z","date":"2025-06-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each time-based restricted stock unit award with respect to shares that is, at the time of determination, subject to vesting or forfeiture conditions and that is not a PSU Award (as defined below) (but including, for clarity, any PSU Award that is subject solely to service-based vesting conditions as of the Effective Time) (\"RSU Award\") that is outstanding as of immediately prior thereto, shall (a) accelerate and become fully vested, and (b) by virtue of the Merger automatically (except as otherwise provided in the Merger Agreement) and without any action on the part of the Issuer, Parent or the holder thereof, be canceled and terminated and converted into the right to receive"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) (i) an amount in cash equal to the product of the number of shares underlying such RSU Award immediately prior to the Effective Time and $3.00 in cash, subject to any applicable withholding taxes and without interest thereon plus (ii) one CVR with respect to each share subject to such RSU Award immediately prior to the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-081175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000095017025081175/ownership.xml","form_type":"4"}},{"id":1124582,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2025-06-03T18:02:16.000Z","date":"2025-05-30","kind":"other","planned":false,"acquired":false,"shares":1143,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of February 21, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Beacon Parent Holdings, L.P. (\"Parent\") and Beacon Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock. Tendering stockholders were given the option to receive per share consideration of either (x) $3.00 in cash per share, subject to any applicable withholding taxes and without interest thereon, plus one contingent value right (\"CVR\") per share, representing the right to receive one contingent payment of $6.84, in cash, subject to any applicable withholding taxes and without interest thereon, upon achievement of the specified milestone or (y) $5.00 in cash per share, subject to any applicable withholding taxes and without interest thereon (collectively, the \"Offer Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of June 2, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0000950170-25-081175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000095017025081175/ownership.xml","form_type":"4"}},{"id":1281657,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-05T16:14:57.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":238,"price":7.3925,"value":1759.415,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range in prices for the transaction reported on this line was $7.27 to $7.55. The average weighted price was $7.3925. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein have been adjusted to reflect a 1-for-20 reverse stock split effected by the Issuer on December 12, 2024."}],"balance_after":4501,"source":{"system":"sec-edgar","filing":"0001562180-25-000951","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218025000951/primarydocument.xml","form_type":"4"}},{"id":1394073,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2024-10-02T16:06:46.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units for common stock vest over a four-year period at the rate of 25% on each of March 1, 2025, March 1, 2026, March 1, 2027 and March 1, 2028. These restricted stock units were approved during the Issuer's regular annual review cycle for 2024 with a delayed date of issuance."}],"balance_after":94783,"source":{"system":"sec-edgar","filing":"0001562180-24-007130","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218024007130/primarydocument.xml","form_type":"4"}},{"id":1595151,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T17:40:11.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":199000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest over a four-year period at the rate of 25% on the first anniversary of March 1, 2024, and then in equal monthly installments for the remaining 36 months."}],"balance_after":199000,"derivative":{"exercise_price":1.56,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":199000},"source":{"system":"sec-edgar","filing":"0001562180-24-002308","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218024002308/primarydocument.xml","form_type":"4"}},{"id":1656671,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-06T16:07:48.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":5217,"price":0.9025,"value":4708.3425,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range in prices for the transaction reported on this line was $0.9011 to $0.9040. The average weighted price was $0.9025. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":44783,"source":{"system":"sec-edgar","filing":"0001562180-24-001096","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218024001096/primarydocument.xml","form_type":"4"}},{"id":2032664,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-02-03T16:05:27.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests over a four-year period at the rate of 25% on 2/1/2024 and then in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":6.38,"expiration_date":"2033-02-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-23-000901","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218023000901/primarydocument.xml","form_type":"4"}},{"id":2032663,"issuer":{"id":78923,"kind":"organization","name":"bluebird bio, Inc.","symbol":"BLUE"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2023-02-03T16:05:27.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit awards vest over a four-year period at the rate of 25% on 2/1/2024, 25% on 2/1/2025, 25% on 2/1/2026, and 25% on 2/1/2027."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001562180-23-000901","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293971/000156218023000901/primarydocument.xml","form_type":"4"}},{"id":2132176,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2022-10-25T16:25:29.000Z","date":"2022-10-21","kind":"sale","acquired":false,"shares":3636,"price":1.39,"value":5054.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\"). The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of shares sold by the broker on behalf of certain executive officers and employees of the company on October 21, 2022.  The broker sold, in the aggregate on behalf of such employees, 21,137 shares in transactions ranging from $1.31 to $1.44 with a weighted average price of $1.39. The proceeds of all such sales were allocated to applicable employees on a pro rata basis based on the number of shares sold by such person. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":31364,"source":{"system":"sec-edgar","filing":"0000899243-22-034122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551776/000089924322034122/doc4.xml","form_type":"4"}},{"id":2231121,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Common Stock","published_at":"2022-06-15T17:05:39.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). One third (1/3) of the total number of RSUs granted vest on October 20, 2022, February 20, 2023 and June 20, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0000899243-22-022621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551776/000089924322022621/doc4.xml","form_type":"4"}},{"id":2368378,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-28T18:48:37.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in equal monthly installments over a four-year period commencing on February 1, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date."}],"balance_after":75000,"derivative":{"exercise_price":8.61,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-013767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551776/000120919122013767/doc4.xml","form_type":"4"}},{"id":2462124,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business & Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-21T16:38:46.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on December 20, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":125000,"derivative":{"exercise_price":9.68,"expiration_date":"2031-12-19","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-21-070782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551776/000120919121070782/doc4.xml","form_type":"4"}},{"id":2778752,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-18T21:33:10.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":60578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-percent (20%) of the shares subject to the option vest on December 7, 2021, and the remaining shares subject to the option shall vest in\nforty-eight (48) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":60578,"derivative":{"exercise_price":17,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":60578},"source":{"system":"sec-edgar","filing":"0001209191-21-021964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551776/000120919121021964/doc4.xml","form_type":"4"}},{"id":2778751,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-18T21:33:10.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":34616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 18, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":34616,"derivative":{"exercise_price":17,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":34616},"source":{"system":"sec-edgar","filing":"0001209191-21-021964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551776/000120919121021964/doc4.xml","form_type":"4"}},{"id":2978796,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer, GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:44:45.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-20-126324","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126324/a4.xml","form_type":"4"}},{"id":2978795,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer, GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:44:45.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-126324","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126324/a4.xml","form_type":"4"}},{"id":2978794,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer, GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:44:45.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-126324","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126324/a4.xml","form_type":"4"}},{"id":2978793,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer, GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:44:45.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-126324","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126324/a4.xml","form_type":"4"}},{"id":2978792,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer, GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:44:45.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-126324","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126324/a4.xml","form_type":"4"}},{"id":2978791,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer, GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:44:45.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-126324","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126324/a4.xml","form_type":"4"}},{"id":2978790,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer, GC"}}],"security":"Common Stock","published_at":"2020-11-17T15:44:45.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":92244,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 1, 2020, by and among the Issuer, Covis Group S.a.r.l. (\"Parent\"), and Covis Mergerco Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), and (in respect of specific matters) Covis Finco S.a r.l., pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of November 16, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive $13.75 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Each Company RSU that is outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash from Parent or the Issuer equal to the Merger Consideration."},{"field":"shares","element":"transactionShares","label":"F3","text":"A portion of this amount consists of unvested performance-based restricted stock units (\"PRSUs\") at the target amount that could have been delivered pursuant to the award. Each Company PRSU that is outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive for each Share underlying such PRSU that would vest at the higher of (i) 100% target performance level, multiplied by a fraction, the numerator of which shall be the number of calendar days from the first day of the Company PRSU's performance measurement period to the Expiration Date and the denominator of which shall be the number of days in the Company PRSU's performance measurement period, or"},{"field":"shares","element":"transactionShares","label":"F4","text":"(ii) the actual level of achievement of performance goals, calculated from the first day of the Company PRSU's performance measurement period through the end of the calendar month immediately preceding the Expiration Date, without interest and subject to deduction for any required withholding taxes, an amount in cash from Parent or the Issuer equal to the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 1, 2020, by and among the Issuer, Covis Group S.a.r.l. (\"Parent\"), and Covis Mergerco Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), and (in respect of specific matters) Covis Finco S.a r.l., pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of November 16, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive $13.75 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Each Company RSU that is outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash from Parent or the Issuer equal to the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"A portion of this amount consists of unvested performance-based restricted stock units (\"PRSUs\") at the target amount that could have been delivered pursuant to the award. Each Company PRSU that is outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive for each Share underlying such PRSU that would vest at the higher of (i) 100% target performance level, multiplied by a fraction, the numerator of which shall be the number of calendar days from the first day of the Company PRSU's performance measurement period to the Expiration Date and the denominator of which shall be the number of days in the Company PRSU's performance measurement period, or"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(ii) the actual level of achievement of performance goals, calculated from the first day of the Company PRSU's performance measurement period through the end of the calendar month immediately preceding the Expiration Date, without interest and subject to deduction for any required withholding taxes, an amount in cash from Parent or the Issuer equal to the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-126324","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126324/a4.xml","form_type":"4"}},{"id":3214555,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-12T16:11:15.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter."}],"balance_after":35000,"derivative":{"exercise_price":7.27,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-20-032483","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920032483/a4.xml","form_type":"4"}},{"id":3214554,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, General Counsel"}}],"security":"Common Stock","published_at":"2020-03-12T16:11:15.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's 2019 Equity Incentive Plan(the \"Plan\") that will vest in three equal annual installments with the first installment vesting on March 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":92244,"source":{"system":"sec-edgar","filing":"0001104659-20-032483","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920032483/a4.xml","form_type":"4"}},{"id":3229619,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, General Counsel"}}],"security":"Common Stock","published_at":"2020-03-04T17:49:33.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":1138,"price":7.75,"value":8819.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 4,000 restricted stock units (\"RSUs\") on March 2, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reporting person's total beneficial ownership has been adjusted to reflect that no shares were awarded pursuant to the performance-based RSU award granted on February 23, 2017.  The reporting person had previously reported beneficial ownership of 7,500 shares pursuant to the RSU award, which represented the target number of shares that could have been delivered based on the achievement of certain relative total stockholder return targets over a three year performance period, which were not met, and which target share amount was previously reported on a Form 4 filed on February 27, 2017."}],"balance_after":67244,"source":{"system":"sec-edgar","filing":"0001104659-20-029291","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920029291/a4.xml","form_type":"4"}},{"id":3250876,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, General Counsel"}}],"security":"Common Stock","published_at":"2020-02-25T16:43:38.000Z","date":"2020-02-25","kind":"tax_withholding","acquired":false,"shares":2206,"price":8.84,"value":19501.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 6,666 restricted stock units on February 25, 2020."}],"balance_after":75882,"source":{"system":"sec-edgar","filing":"0000792977-20-000016","document":"wf-form4_158266697117170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297720000016/wf-form4_158266697117170.xml","form_type":"4"}},{"id":3250875,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, General Counsel"}}],"security":"Common Stock","published_at":"2020-02-25T16:43:38.000Z","date":"2020-02-23","kind":"tax_withholding","acquired":false,"shares":867,"price":9.5,"value":8236.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,501 restricted stock units on February 23, 2020."}],"balance_after":78088,"source":{"system":"sec-edgar","filing":"0000792977-20-000016","document":"wf-form4_158266697117170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297720000016/wf-form4_158266697117170.xml","form_type":"4"}},{"id":3603267,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-11T16:41:42.000Z","date":"2019-03-07","kind":"sale","acquired":false,"shares":1425,"price":14.01,"value":19964.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction on this Form 4 was automatically effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2018 in order to cover incremental taxes on the vesting of previous restricted stock unit grants."}],"balance_after":78955,"source":{"system":"sec-edgar","filing":"0000792977-19-000052","document":"wf-form4_155233688756441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000052/wf-form4_155233688756441.xml","form_type":"4"}},{"id":3616340,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-05T18:07:41.000Z","date":"2019-03-02","kind":"tax_withholding","acquired":false,"shares":1146,"price":14.76,"value":16914.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 3,999 restricted stock units on March 2, 2019."}],"balance_after":80380,"source":{"system":"sec-edgar","filing":"0000792977-19-000046","document":"wf-form4_155182724598001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000046/wf-form4_155182724598001.xml","form_type":"4"}},{"id":3616339,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-05T18:07:41.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":986,"price":14.76,"value":14553.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 3,001 restricted stock units on March 1, 2019."}],"balance_after":81526,"source":{"system":"sec-edgar","filing":"0000792977-19-000046","document":"wf-form4_155182724598001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000046/wf-form4_155182724598001.xml","form_type":"4"}},{"id":3630283,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-27T18:25:32.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter."}],"balance_after":25000,"derivative":{"exercise_price":15.51,"expiration_date":"2029-02-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000792977-19-000028","document":"wf-form4_155130991647075.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000028/wf-form4_155130991647075.xml","form_type":"4"}},{"id":3630282,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-02-27T18:25:32.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares of Common Stock are issuable pursuant to a performance-based RSU grant under a long-term incentive program under the Plan and will be earned, if at all, based on achievement of certain relative total stockholder return targets over the three year performance period ending February 25, 2022 subject to continuation of a business relationship with the grantee through the conclusion of the performance period. The number above represents the target number of shares that may be delivered pursuant to the award (\"Target Award\"); however, the amount that vests could range from zero to 150% of the Target Award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":82512,"source":{"system":"sec-edgar","filing":"0000792977-19-000028","document":"wf-form4_155130991647075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000028/wf-form4_155130991647075.xml","form_type":"4"}},{"id":3630281,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-02-27T18:25:32.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan, as amended (the \"Plan\") that will vest in three equal annual installments with the first installment vesting on February 25, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":70512,"source":{"system":"sec-edgar","filing":"0000792977-19-000028","document":"wf-form4_155130991647075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000028/wf-form4_155130991647075.xml","form_type":"4"}},{"id":3634182,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-02-26T17:44:30.000Z","date":"2019-02-23","kind":"tax_withholding","acquired":false,"shares":869,"price":15.51,"value":13478.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,500 restricted stock units on February 23, 2019."}],"balance_after":50512,"source":{"system":"sec-edgar","filing":"0000792977-19-000021","document":"wf-form4_155122105598895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000021/wf-form4_155122105598895.xml","form_type":"4"}},{"id":3833324,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-08-27T16:17:09.000Z","date":"2018-08-24","kind":"tax_withholding","acquired":false,"shares":1473,"price":24.6,"value":36235.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 5,001 restricted stock units on August 24, 2018."}],"balance_after":51381,"source":{"system":"sec-edgar","filing":"0000792977-18-000057","document":"wf-form4_153540101316279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297718000057/wf-form4_153540101316279.xml","form_type":"4"}},{"id":4012816,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-06T19:25:27.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter."}],"balance_after":20000,"derivative":{"exercise_price":21,"expiration_date":"2028-03-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-18-003697","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911018003697/edgar.xml","form_type":"4"}},{"id":4012815,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-06T19:25:27.000Z","date":"2018-03-06","kind":"sale","acquired":false,"shares":770,"price":20.8,"value":16016.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2017."}],"balance_after":52854,"source":{"system":"sec-edgar","filing":"0001179110-18-003697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911018003697/edgar.xml","form_type":"4"}},{"id":4012814,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-06T19:25:27.000Z","date":"2018-03-02","kind":"tax_withholding","acquired":false,"shares":1011,"price":21,"value":21231.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 3,000 RSUs on March 1, 2018. Due to the black-out policies implemented by the Issuer, the shares of the Issuer's Common Stock underlying such vested RSUs were not delivered to the reporting person until March 2, 2018, at which time an aggregate of 1,011 shares were withheld to satisfy the reporting person's applicable tax obligations."}],"balance_after":53624,"source":{"system":"sec-edgar","filing":"0001179110-18-003697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911018003697/edgar.xml","form_type":"4"}},{"id":4012813,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-06T19:25:27.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F5","text":"These shares of Common Stock are issuable pursuant to a performance-based RSU grant under a long-term incentive program under the Plan and will be earned, if at all, based on achievement of certain relative total stockholder return targets over the three year performance period ending March 1, 2021 subject to continuation of a business relationship with the grantee through the conclusion of the performance period. The number above represents the target number of shares that may be delivered pursuant to the award (\"Target Award\"); however, the amount that vests could range from zero to 150% of the Target Award."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."}],"balance_after":54635,"source":{"system":"sec-edgar","filing":"0001179110-18-003697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911018003697/edgar.xml","form_type":"4"}},{"id":4012812,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-06T19:25:27.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's Fourth Amended and Restated 2007 Equity Incentive Plan (as amended the \"Plan\") and will vest in three equal annual installments with the first installment vesting on March 2, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."}],"balance_after":44635,"source":{"system":"sec-edgar","filing":"0001179110-18-003697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911018003697/edgar.xml","form_type":"4"}},{"id":4012811,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-06T19:25:27.000Z","date":"2018-02-23","kind":"tax_withholding","acquired":false,"shares":869,"price":19.65,"value":17075.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,499 restricted stock units (\"RSUs\") on February 23, 2018."}],"balance_after":32635,"source":{"system":"sec-edgar","filing":"0001179110-18-003697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911018003697/edgar.xml","form_type":"4"}},{"id":4222161,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2017-08-30T16:03:13.000Z","date":"2017-08-29","kind":"sale","acquired":false,"shares":1250,"price":16.75,"value":20937.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2017."}],"balance_after":33504,"source":{"system":"sec-edgar","filing":"0001179110-17-011890","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017011890/edgar.xml","form_type":"4"}},{"id":4224047,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2017-08-28T16:27:11.000Z","date":"2017-08-24","kind":"tax_withholding","acquired":false,"shares":1633,"price":17.5,"value":28577.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 5,000 restricted stock units on August 24, 2017. 1,633 shares were withheld to satisfy the reporting person's applicable tax obligations."}],"balance_after":34754,"source":{"system":"sec-edgar","filing":"0001179110-17-011859","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017011859/edgar.xml","form_type":"4"}},{"id":4327363,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2017-05-10T16:45:51.000Z","date":"2017-05-08","kind":"tax_withholding","acquired":false,"shares":980,"price":18.55,"value":18179.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,999 restricted stock units (\"RSUs\") on March 1, 2017. Due to the black-out policies implemented by AMAG Pharmaceuticals, Inc. (the \"Issuer\"), the shares of the Issuer's Common Stock underlying such vested RSUs were not delivered to the reporting person until May 8, 2017, at which time 980 shares were withheld to satisfy the reporting person's applicable tax obligations."}],"balance_after":36387,"source":{"system":"sec-edgar","filing":"0001179110-17-006985","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017006985/edgar.xml","form_type":"4"}},{"id":4423067,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-27T19:03:29.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter."}],"balance_after":20000,"derivative":{"exercise_price":23.75,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-17-003323","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017003323/edgar.xml","form_type":"4"}},{"id":4423066,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2017-02-27T19:03:29.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares of Common Stock are issuable pursuant to a performance-based RSU grant under a long-term incentive program under the Plan and will be earned, if at all, based on achievement of certain relative total stockholder return targets over the three year performance period ending December 31, 2019, subject to continuation of a business relationship with the grantee through the conclusion of the performance period. The number above represents the target number of shares that may be delivered  pursuant to the award (\"Target Award\"); however, the amount that vests could range from zero to 150% of the Target Award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":37367,"source":{"system":"sec-edgar","filing":"0001179110-17-003323","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017003323/edgar.xml","form_type":"4"}},{"id":4423065,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":63877,"kind":"person","name":"Vittiglio Joseph","position":1,"cik":"0001551776","reported_name":"Vittiglio Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2017-02-27T19:03:29.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's Third Amended and Restated 2007 Equity Incentive Plan (as amended the \"Plan\") and will vest in three equal annual installments with the first installment vesting on February 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":29867,"source":{"system":"sec-edgar","filing":"0001179110-17-003323","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017003323/edgar.xml","form_type":"4"}}]}